Navalign LLC Sells 88 Shares of UnitedHealth Group Incorporated (NYSE:UNH)

Navalign LLC cut its position in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 7.3% in the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 1,111 shares of the healthcare conglomerate’s stock after selling 88 shares during the period. Navalign LLC’s holdings in UnitedHealth Group were worth $585,000 at the end of the most recent quarter.

Several other hedge funds and other institutional investors have also recently modified their holdings of UNH. Robbins Farley bought a new stake in shares of UnitedHealth Group in the 3rd quarter valued at about $25,000. Richelieu Gestion SA acquired a new position in UnitedHealth Group in the 4th quarter worth approximately $26,000. CGC Financial Services LLC lifted its holdings in shares of UnitedHealth Group by 1,000.0% in the 4th quarter. CGC Financial Services LLC now owns 55 shares of the healthcare conglomerate’s stock valued at $29,000 after buying an additional 50 shares during the period. NewSquare Capital LLC grew its position in UnitedHealth Group by 340.0% during the third quarter. NewSquare Capital LLC now owns 66 shares of the healthcare conglomerate’s stock valued at $33,000 after buying an additional 51 shares during the period. Finally, Strategic Investment Solutions Inc. IL acquired a new position in shares of UnitedHealth Group during the 1st quarter worth approximately $35,000. 87.86% of the stock is currently owned by hedge funds and other institutional investors.

Insider Activity at UnitedHealth Group

In related news, EVP Erin Mcsweeney sold 1,236 shares of the firm’s stock in a transaction dated Friday, March 8th. The stock was sold at an average price of $483.48, for a total value of $597,581.28. Following the transaction, the executive vice president now owns 9,364 shares in the company, valued at $4,527,306.72. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. In related news, CAO Thomas E. Roos sold 858 shares of the business’s stock in a transaction that occurred on Friday, February 23rd. The stock was sold at an average price of $525.79, for a total value of $451,127.82. Following the completion of the transaction, the chief accounting officer now directly owns 32,289 shares in the company, valued at approximately $16,977,233.31. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, EVP Erin Mcsweeney sold 1,236 shares of the business’s stock in a transaction on Friday, March 8th. The shares were sold at an average price of $483.48, for a total transaction of $597,581.28. Following the completion of the sale, the executive vice president now directly owns 9,364 shares in the company, valued at $4,527,306.72. The disclosure for this sale can be found here. 0.35% of the stock is currently owned by company insiders.

UnitedHealth Group Stock Up 0.3 %

Shares of NYSE:UNH traded up $1.60 during mid-day trading on Thursday, hitting $494.70. 3,805,551 shares of the company traded hands, compared to its average volume of 4,097,774. The firm has a market cap of $456.08 billion, a P/E ratio of 20.70, a PEG ratio of 1.34 and a beta of 0.54. The firm’s 50 day simple moving average is $503.10 and its 200 day simple moving average is $518.61. The company has a debt-to-equity ratio of 0.62, a quick ratio of 0.79 and a current ratio of 0.79. UnitedHealth Group Incorporated has a 52-week low of $445.68 and a 52-week high of $554.70.

UnitedHealth Group (NYSE:UNH) last announced its quarterly earnings data on Friday, January 12th. The healthcare conglomerate reported $6.16 EPS for the quarter, topping analysts’ consensus estimates of $5.98 by $0.18. UnitedHealth Group had a return on equity of 26.39% and a net margin of 6.02%. The company had revenue of $94.43 billion during the quarter, compared to the consensus estimate of $92.13 billion. During the same quarter last year, the company earned $5.34 EPS. The company’s quarterly revenue was up 14.1% on a year-over-year basis. On average, equities analysts anticipate that UnitedHealth Group Incorporated will post 27.82 EPS for the current year.

UnitedHealth Group Dividend Announcement

The firm also recently disclosed a quarterly dividend, which was paid on Tuesday, March 19th. Shareholders of record on Monday, March 11th were paid a $1.88 dividend. This represents a $7.52 dividend on an annualized basis and a yield of 1.52%. The ex-dividend date was Friday, March 8th. UnitedHealth Group’s dividend payout ratio is currently 31.54%.

Analyst Ratings Changes

Several analysts recently issued reports on the stock. Royal Bank of Canada reaffirmed an “outperform” rating and set a $596.00 price objective on shares of UnitedHealth Group in a research note on Thursday, February 29th. Bank of America restated a “buy” rating and set a $675.00 target price on shares of UnitedHealth Group in a report on Thursday, March 7th. Oppenheimer reiterated an “outperform” rating and set a $610.00 price target on shares of UnitedHealth Group in a report on Wednesday, January 17th. HSBC reiterated a “reduce” rating and set a $480.00 target price (down previously from $550.00) on shares of UnitedHealth Group in a research report on Monday, December 18th. Finally, Barclays initiated coverage on UnitedHealth Group in a research report on Wednesday, March 6th. They set an “overweight” rating and a $551.00 price objective for the company. One analyst has rated the stock with a sell rating, two have issued a hold rating, fifteen have assigned a buy rating and one has issued a strong buy rating to the company’s stock. Based on data from MarketBeat.com, UnitedHealth Group presently has a consensus rating of “Moderate Buy” and an average price target of $579.33.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.